Share on StockTwits

Synergy Health Plc (LON:SYR)‘s stock had its “buy” rating reaffirmed by analysts at Investec in a research report issued to clients and investors on Friday, Stock Ratings Network reports. They currently have a GBX 1,450 ($24.42) price objective on the stock. Investec’s price objective indicates a potential upside of 16.12% from the company’s current price.

A number of other analysts have also recently weighed in on SYR. Analysts at Numis Securities Ltd reiterated an “add” rating on shares of Synergy Health Plc in a research note on Friday. They now have a GBX 1,380 ($23.24) price target on the stock. Separately, analysts at Canaccord Genuity downgraded shares of Synergy Health Plc to a “sell” rating in a research note on Monday, April 7th. They now have a GBX 987 ($16.62) price target on the stock, up previously from GBX 979 ($16.49). Finally, analysts at N+1 Singer raised their price target on shares of Synergy Health Plc from GBX 1,200 ($20.21) to GBX 1,258 ($21.19) in a research note on Tuesday, March 11th. They now have a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of GBX 1,217.14 ($20.50).

Synergy Health Plc (LON:SYR) opened at 1219.00 on Friday. Synergy Health Plc has a 52 week low of GBX 991.00 and a 52 week high of GBX 1437.00. The stock has a 50-day moving average of GBX 1292. and a 200-day moving average of GBX 1226.. The company’s market cap is £714.3 million.

Synergy Health plc delivers a range of specialist outsourced services to healthcare providers and other customers concerned with health management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.